Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine Adjuvant Therapy in Schizophrenia
NCT01946295Phase 3Unknown
- Start
- Mar 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of famotidine in schizophrenia. Status: unknown.
02
Drugs
famotidine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01946295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01946295.